AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2641-0419/374
1Turkiye Yuksek Ihtisas Research and Training Hospital, Cardiovascular Surgery
2Cardiovascular Surgery Department, Hacettepe University
3Ankara, Turkiye Yuksek Ihtisas Research and Training Hospital, Anesthesia and Reanimation
4Biochemistry Department4, Ankara, Turkey.
*Corresponding Author: A.Tulga Ulus, Cardiovascular Surgery Department, Hacettepe University.
Citation: A.Tulga Ulus, Ayşegül Özgök, Sertan Özyalçın, Gül Saydam, Mevhibe Balk, et.al, (2024), Uncontrolled diabetes mellitus; results of cytokines and endothelial function during coronary artery bypass surgery, J Clinical Cardiology and Cardiovascular Interventions, 7(6); DOI: 10.31579/2641-0419/374
Copyright: © 2024, A.Tulga Ulus. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 22 April 2024 | Accepted: 28 June 2024 | Published: 07 June 2024
Keywords: diabetes mellitus; cytokines; endothelial function and coronary artery bypass surgery
Objective: Unregulated type 2 diabetes mellitus is a major risk factor for coronary artery bypass surgery [CABG]. Perioperative values of cytokines and the endothelial function of diabetic patients who have controlled and uncontrolled glucose were compared according to HbA1c levels. The parameters were analyzed and compared following the hospital admission and started to the appropriate treatment.
Methods: Forty patients undergoing CABG were included the study. Patients were divided into 3 groups according to preoperative HbA1c levels; the patients who had HbA1c level below 7 [group 2], HbA1c values in between 7-10 [group 3], above 10 [group 4] were marked as groups 1-3 and additional 10 non diabetic patients were included as the control group [group 1].
Results: The demographic data of the patients were not significantly changed among the groups except female gender. Postoperative inotropic support necessity was high especially in group 4. Preoperative endothelial dysfunction was also severely impaired in the high HbA1c groups but this difference was returned to nonsignificant level following treatment. Noninvasive endothelial function was calculated as 2.0 in control group but 0.69±0.32, 1.36±0.69, 0.99±0.15 in groups 2-4. Apelin, soluble intercellular adhesion molecule and Platelet Activating Factor levels were changed significantly among the groups [p<0.002].
Conclusion: We indicate that HbA1c level is an important predictor of morbidity during the CABG surgery. In our study there is a significant difference between diabetic and non-diabetic patients in terms of both endothelial function and some of the inflammatory cytokines. These parameters improved by the time and following the appropriate treatment of diabetes mellitus but effect the CABG surgery
Diabetes mellitus [DM] is one of the major risk factor in coronary artery disease [CAD] and atherosclerosis is responsible for mortality and morbidity in diabetic patients. Coronary artery bypass grafting [CABG] surgery is recommended in patients with DM and multivessel CAD to improve survival free from major cardiovascular events [1-7]. DM increases the long term mortality and risk of complications after CABG surgery compared with non-diabetic patients [8]. DM is an inflammatory, proliferative and prothrombotic disease. As a result of DM, increased platelet activity and a predisposition to coagulation, adverse effects on lipid metabolism, corrupted function of polymorph nuclear leucocytes and fibroblast proliferation, and disorders of endothelial activity may occur. There is an important correlation between blood glucose levels and the severity of disorders. HbA1c is a parameter that specifies the blood glucose regulation. Some studies presented the relationship between preoperative HbA1c levels and postoperative outcomes following CABG surgery in diabetic patients [9-11].
Endothelial dysfunction is one of the major pathologic component of CAD and DM [12-17]. Therefore, noninvasive methods have been developed to reveal endothelial dysfunction. Reactive hyperemia-peripheral arterial tonometry [RH-PAT] is a noninvasive method to assess the peripheral endothelial function [18, 19].
Patients, who had uncontrolled blood glucose levels have the highest morbidity and mortality [1]. We aimed to find out a parameter that may inform us before the surgery for the optimum timing of surgery related with the blood glucose level and diabetic severity. The purpose of this study is to determine the relationship between the level of endothelial dysfunction, inflammatory processes by measuring cytokine levels and blood glucose levels in diabetic patients who experienced CABG.
This study is a prospective randomized clinical study. The ethical committee approval was completed with the registration number 20-412. Forty-one patients who were operated for CAD in our clinic, included in this study. Patients were divided into four groups according to HbA1c levels that were obtained when they applied to the hospital first. These groups were as follows; Group 1 [10 patients] was nondiabetic patients with HbA1c<4>[table 1] but other demographic variables are statistically non-significant among the groups
| Variables | Group 1 [HbA1C<4> N=10 | Group 2 [HbA1C 4-7] N=11 | Group 3 [HbA1C 7-10] N=12 | Group 4 [HbA1C >10] N=8 | P |
| Male | 5 [50%] | 9 [81.8%] | 12 [100%] | 5 [62.5%] | 0.047 |
| Age | 56.1±12.2 | 58.5±8.4 | 59.4±7.8 | 61.7±8 | 0.6 |
| BMI | 1.16±0.8 | 1.3±0.6 | 1.4±0.6 | 1.2±0.8 | 0.57 |
| OAD | 4 [36%] | 6 [50%] | 3 [37.5%] | 0.2 | |
| Insulin | 1 [8.3%] | 5 [62%] | 0.001 | ||
| DM Follow-up year | 4.9±5.6 | 9.4±8.9 | 9.3±9 | 0.01 | |
| Hypertension | 5 [50%] | 9 [81.8%] | 8 [66.7%] | 7 [87.5%] | 0.27 |
| Hyperlipidemia | 2 [20%] | 6 [54.5%] | 4 [30%] | 5 [62.5%] | 0.21 |
| Preoperative MI History | 1 [10%] | 2 [18.2%] | 2 [16.6%] | 4 [50%] | 0.18 |
| Preoperative Stroke History | 1 [9.1%] | 2 [16.6%] | 0.38 | ||
| Peripheral arterial disease | 1 [9.1%] | 2 [18.2%] | 0.46 | ||
| Preoperative EF [%] | 57.3±5.3 | 57.3±6.6 | 56±6.1 | 52.5±10 | 0.4 |
| Preoperative NYHA Class 1+2 | 8 [80%] | 9 [81.8%] | 10 [83.3%] | 5 [62.5%] |
0.16 |
| Preoperative NYHA Class 3 | 2 [20%] | 2 [18.2%] | 1 [8.3%] | 3 [37.5%] | |
| Preoperative medications | |||||
| Asetilsalisilic Asit | 3 [30%] | 7 [63.6%] | 1 [8.3%] | 5 [62.5%] | 0.02 |
| Beta Blokors | 7 [70%] | 8 [80%] | 3 [25%] | 4 [50%] | 0.08 |
| Ace Inhibitors | 5 [50%] | 8 [80%] | 5 [41.6%] | 5 [50%] | 0.47 |
DM: Diabetes Mellitus, BMI: Body Mass Index, OAD: Oral Antidiabetics.
Table 1: Demographic variables according to the groups [p<0>
Patients were hospitalized minimum 2-days before the surgery in order to regulate blood glucose levels. Except metformin, the oral antidiabetic medications are continued and if the glycemic control is not effective, insulin regiment is started to regulate blood glucose levels. 200 mg/dl blood glucose level is the cutoff level to obtain permission for the operation. The blood glucose level during the operation was controlled by insulin infusion. We use the Portland Protocol peroperatively [20].
We studied RH- PAT system two times on all patients before the surgery as baseline and 7 day following the CABG surgery to evaluate the endothelial dysfunction and effects on DM and CABG surgery. The RH-PAT system is a rapid and noninvasive technique that is used to assess endothelial vasodilator function, duplex ultrasonography is the most common technique to assess flow-mediated vasodilation, but this technique is operator dependent and takes time. The equipment for Rh-PAT system is cheaper than duplex ultrasonography. This device [Endopat 2000, Itamar Medical Ltd., Caesarea, Israel] consists of two probes which are mounted to fingers. These probes includes inflatable latex air-cushions within a rigid external case. Endothelium-mediated changes in the digital pulse waveforms are recorded by PAT [peripheral Arterial Tone] device. The changes in the PAT signal are elicited by creating a downstream hyperemic response. Hyperemia is induced by occluding blood flow through the brachial artery for 5 minutes using an inflatable cuff on one hand. Reactive hyperemia automatically calculated by the system. By calculation of pre and post occlusion n values, a PAT ratio is created. These values are normalized to measurements from the contra-lateral arm. This arm serves as control for non-endothelial systemic effects. The RH-PAT studies were performed in the supine position and both hands on the same level of the patient. One of the upper arms is chosen for placing for blood pressure cuff [study arm], while the contralateral arm served as a control [control arm]. Finger I of each hands are used to place RH-PAT probes. Pulsatile blood volume responses from both hands were recorded continuously. After 5 minutes of first recording period, the blood pressure cuff on the study arm was inflated to 60 mm Hg above systolic pressure for 5 min. The cuff was then deflated to induce RH, whereas PAT recording was continued for five minutes. The response to reactive hyperemia is calculated automatically by the system. Pat ratio is below 1.5 is severe endothelial dysfunction, 1.5 – 2.1 is moderate endothelial dysfunction and 2.1 and above is normal endothelial functions is determined by the manufacturer. EndoPat results are shown in table 2.
| Variables | Group 1 [HbA1C<4> N=10 | Group 2 [HbA1C 4-7] N=11 | Group 3 [HbA1C 7-10] N=12 | Group 4 [HbA1C >10] N=8 | P |
| Preoperative endothelial function | 2.00±0.42 | 0.69±0.32 | 1.36±0.69 | 0.99±0.15 | 0.01 |
Postoperative endothelial function | 1.56±0.25 | 1.86±0.37 | 1.54±0.44 | 1.22±0.32 | 0.15 |
Table 2: Preoperative and postoperative endothelial function [Endopat] measurements [p<0>
Surgical Intervention
All patients have multivessel coronary artery disease including proximal left anterior descending artery [LAD] or left main coronary artery (LMCA). Left internal thoracic artery [LITA] is used for LAD in all patients. Other coronary arteries are bypassed by using saphenous vein grafts. We have used mean 2.9 ± 0.8 grafts / patient in this study.
The CABG was performed with standard cardiopulmonary bypass technique and using cross-clamp. Myocardial protection was established by hypothermia (28-30 °C), topical cooling and initial cold crystalloid cardioplegia followed by blood cardioplegia solution [Plegisol-ABBOT©] were applied in 20-minute intervals. The last dose of cardioplegia was given as warm blood cardioplegia. A moderate degree of hypothermia and hemodilution was used. Operative and postoperative data are given in table 3.
Inflammatory Cytokines
We studied cytokine levels at four time points to evaluate inflammatory processes and its’ effects in diabetic patients. We collected blood samples during and after CABG surgery as; before the induction of anesthesia, when the cardiopulmonary bypass was started, when the cardiopulmonary bypass was ended and at first postoperative day. Soluble vascular adhesion molecule-1 [sVCAM-1], soluble intercellular adhesion molecule-1 [sICAM-1], soluble E-selectin [sE-selectin] and soluble P-selectin [sP-selectin] were measured in duplicate using commercially available enzyme-linked immunosorbent assay [ELISA] kits. [RayBiotech®, Georgia,USA]. IL-6, IL-1β and TNFα were measured in duplicate using commercially available enzyme amplified sensitivity immunoassay kits [Diasource®, Nivelles, Belgium]. Also Endotelin -1, Nitric Oxide [NO], Myeloperoxidase [MPO], Homocysteine, Asymmetric dimethyl-L-arginin [ADMA], Von Wilebrand Factor [VWF], Platelet Activating Factor [PAF] and Apelin were measured in duplicate using comerciallay avaiable ELİSA kits. [Biomedica®, Wien, Austria], [Enzolifesiences®, New York, USA], [eBioscience®, Vienna, Austria], [Axis-Shield Diagnostics®, Dundee, UK], Immundiagnostik®, Bensheim, Germany], [Assaypro®, Missouri, USA], [Life Science Inc.®, Wuhan,China], [Phoneix Pharmaceuticals Inc®., California, USA] were analyzed with immunoassay kits respectively. The cytokine levels are given in Table 4.
Statistical Analysis
One way ANOVA test was used for statistical comparison of continuous variables between the groups. Chi-square test was used for comparison of categorical variables between the groups. Paired t-test was also used to determine the differences in the same group during the different measurement intervals. All values were reported as mean±SD. A p-value <0>
Results
There was no difference in between the groups in terms of age. Mean age of all patients was 58.8±9.1 [38 to 78]. Male gender is more dominant in all groups. The use of insulin and diabetic patient follow up time are increased relative to level of HbA1c [p=0.001, p=0.01 respectively] [Table 1]. In terms of concomitant diseases, preoperative medications, preoperative MI and stroke history were similar in all groups.
Endothelial dysfunction was measured by using the Rh-Pat system moderate to severe levels. The mean Pat ratio measured 2.00±0.42 in control group [group 1] but 0.69±0.32, 1.36±0.69, 0.99±0.15 in groups 2, 3 and 4 preoperatively [p<0>0.05] postoperatively. The positive inotropic support ratio is higher in diabetic groups but group 4 has the highest ratio with 50% [p<0>table 3].
| Variables | Group 1 [HbA1C<4> N=10 | Group 2 [HbA1C 4-7] N=11 | Group 3 [HbA1C 7-10] N=12 | Group 4 [HbA1C >10] N=8 | P |
| Cross clamp Time [min] | 49±20 | 62±24 | 58±10 | 69±20 | 0.2 |
| CPB Time [min] | 81±35 | 103±19 | 96±21 | 113±25 | 0.07 |
| Number of CABG grafts | 2.6±1.0 | 3.1±0.6 | 3±0.6 | 2.8±1.2 | 0.53 |
| Postop bleeding [ml] | 738±448 | 520±220 | 662±518 | 668±315 | 0.65 |
| Extubation time [Hour] | 11±5.2 | 7.3±2.8 | 9.8±3.7 | 11.3±4.1 | 0.1 |
| ICU Stay [days] | 1.3±0.9 | 1±0.3 | 1±0.3 | 1.25±0.7 | 0.5 |
| Postoperative inotropic support | 0.0 % | 18.2 % | 8.3 % | 50.0 % | 0.03 |
| Hospital Stay [days] | 5.9±1.6 | 5.3±0.8 | 6.3±4.5 | 6.25±1.4 | 0.8 |
CPB: Cardio Pulmonary Bypass, ICU: Intensive Care Unit
Table 3: Operative and postoperative measurements [p<0>
We studied cytokine levels at four different time points as baseline [preoperatively] and postoperatively [when the cardiopulmonary bypass was started, when the cardiopulmonary bypass was ended and at first postoperative day]. The cytokine levels according to the diabetic severity presented many important results. Nitric oxide levels did not differ among the groups but it decreased significantly in group 1, control group. It slightly but nonsignificantly increased in group 3 and 4 that could be explained by the result of insulin treatment. Soluble vascular adhesion molecule levels did not differ among the groups but significantly increased in all groups during the follow up. Soluble intercellular adhesion molecule levels reached a significant level at the 4th measurement point [at first postoperative day], with the lowest value at group 4 [p<0>[Table 4].
Variables
| Group 1 [HbA1C<4> | Group 2 [HbA1C 4-7] | Group 3 [HbA1C 7-10] | Group 4 [HbA1C >10] | P |
| Nitricoxide [24-54 µmol/L] | |||||
| NO 1 | 68.1±35.9 | 53.9±29.4 | 57.1±38.2 | 61.9±36.4 | 0.5 |
| NO 2 | 38.3±17.2* | 51.5±24.7 | 55±37.7 | 71.2±29.5 | 0.3 |
| NO 3 | 59.3±28.8* | 51±21.1 | 42.6±29.3 | 76.8±28 | 0.1 |
| NO 4 | 55.0±11.9 | 51.3±29.6 | 81.5.±48.4 | 51.1±35.7 | 0.88 |
| P [in group] | * | - | - | - | - |
| SVCAM1 [134-550 ng/ml] [soluble vascular adhesion molecule] | |||||
| SVCAM 1 | 488.4±87.8* | 469.3±83.3* | 488.5±73.5* | 489.8±61.2* | 0.32 |
| SVCAM 2 | 568.4±72.9* | 533.5±54.1* | 550.7±46.5* | 546.4±82.8* | 0.41 |
| SVCAM 3 | 585.2±68.3* | 557.7±55.2 | 550.7±46.5 | 589.9±44.2 | 0.41 |
| SVCAM 4 | 525.9±46.7 | 518.2±88.8 | 540.3±41.6 | 575.2±37.7 | 0.19 |
| P [in group] | * | * | * | * | - |
| SICAM [152-362 ng/ml] [soluble intercellular adhesion molecule] | |||||
| SICAM 1 | 135±32.4* | 142.4±26.4* | 146.6±27.2* | 131.6±31* | 0.62 |
| SICAM 2 | 157±34.8* | 157.4±25.6* | 177.3±25.6* | 154.1±24.6* | 0.39 |
| SICAM 3 | 170.5±41.9* | 165.8±33.5* | 184.7±23.3* | 180.6±43.2* | 0.45 |
| SICAM 4 | 152.2±19.2 | 157.4±35.7 | 181.2±26.8 | 135.2±25.4* | 0.04 |
| P [in group] | * | * | * | * | - |
| E-SELECTIN [20.3-105.5 mg/L] | |||||
| ESELECTIN 1 | 31.8±12.9* | 30.9±7.6* | 32.1±14.5* | 22.7±9.3* | 0.47 |
| ESELECTIN 2 | 21.7±6.5* | 22.2±5.8* | 25.1±12.9* | 19.2±8.1* | 0.8 |
| ESELECTIN 3 | 30.3±13.2 | 29.5±9.3 | 28.2±11.6 | 21.7±9.9 | 0.76 |
| ESELECTIN 4 | 25.3±9.9* | 28.2±6.9 | 23.8±9.7 | 21.7±9.9 | 0.76 |
| P [in group] | * | * | * | * | - |
| P-SELECTIN [84-213 mg/L] | |||||
| P-SELECTIN 1 | 237.8±110.4 | 174.4±49.0 | 169.4±62.9 | 195.5±91.7 | 0.21 |
| P-SELECTIN 2 | 160.3±48.0 | 191.8±86.3 | 171.4±71.7 | 188.0±124.1 | 0.76 |
| P-SELECTIN 3 | 186.3±55.4 | 205.6±116.8 | 198.7±111.7 | 168.0±73.8 | 0.93 |
| P-SELECTIN 4 | 152.7±73.1 | 159.5±44.7 | 164.6±116.4 | 162.5±92.7 | 0.98 |
| P [in group] | - | - | - | - | - |
| Interleukin 6 [0-50 pg/ml] | |||||
| IL6 1 | 29.2±19.5* | 21.4±4.3* | 30.4±24.2* | 39.6±33.2* | 0.41 |
| IL6 2 | 254±219.8* | 328±180.1* | 400.0±157.3* | 401.4±206.7* | 0.3 |
| IL6 3 | 128.1±103.3* | 157.2±120.9* | 199.4±120.9* | 229.9±145.1* | 0.28 |
| IL6 4 | 53.4±18.3* | 46.9±13.1* | 49±13.1* | 77±43.7* | 0.07 |
| P [in group] | * | * | * | * | - |
| ENDOTHELIN [0.36-1.14 pg/ml] | |||||
| ENDOTELIN 1 | 0.69±0.43* | 0.50±0.16* | 0.52±0.29* | 0.47±0.28* | 0.38 |
| ENDOTELIN 2 | 0.37±0.23* | 0.21±0.09* | 0.26±0.14* | 0.21±0.12* | 0.12 |
| ENDOTELIN 3 | 0.49±0.26 | 0.36±0.29 | 0.43±0.22 | 0.56±0.32 | 0.29 |
| ENDOTELIN 4 | 0.63±0.29 | 0.44±0.32 | 0.56±0.25 | 0.60±0.36 | 0.65 |
| P [in group] | * | * | * | * | - |
| Interleukin 1β [0-17 pg/ml] | |||||
| IL1β 1 | 62.3±41.5 | 50.8±31.0 | 30.8±12.3 | 43.7±22.6 | 0.17 |
| IL1β 2 | 34.1±15.4 | 60.1±30.3 | 36.2±18.5 | 46.2±19.7 | 0.06 |
| IL1β 3 | 38±11.2 | 37.1±18.4 | 28.4±11.5 | 34.9±26.8 | 0.4 |
| IL1β 4 | 42.5±16.2 | 33.4±15.9 | 28.1±16.5 | 25.1±16.9 | 0.12 |
| P [in group] | - | - | - | - | - |
| TNFα [4.6-12.4 pg/ml] | |||||
| TNF 1 | 8.2±6.2* | 5.5±2.1* | 6.7±3.6* | 9.6±7.1 | 0.37 |
| TNF 2 | 13.3±8.0* | 14.8±11.0* | 13.7±7.9* | 21.9±12.7 | 0.25 |
| TNF 3 | 9.7±5.4 | 8.8±6.3 | 11.1±10.8 | 15.7±12.7 | 0.33 |
| TNF 4 | 9.3±3.6 | 11.4±4.2* | 9.4±2.7* | 9.7±3.5 | 0.61 |
| P [in group] | * | * | * | - | - |
| Platelet Activating Factor [72-160 pg/mol] | |||||
| PAF 1 | 184.4±116.8* | 200.6±43.6* | 119.5±64.6* | 192.8±81.0* | 0.17 |
| PAF 2 | 89.1±62.7* | 77.5±44.5* | 60.9±25.4* | 98.5±50.7* | 0.49 |
| PAF 3 | 140.5±91.5* | 108.7±39.7* | 83.4±24.3* | 108.5±52.9* | 0.15 |
| PAF 4 | 188.6±102.4 | 141.6±47.1* | 80.0±32.2 | 187.5±90.4 | 0.03 |
| P [in group] | * | * | * | * | - |
| Myeloperoxidase [1.45-72.67 ng/ml] | |||||
| MPO 1 | 21.8±15.9* | 18.5±13.6* | 11.5±6.0* | 17.8±7.8* | 0.22 |
| MPO 2 | 39±29.1* | 34.2±30.5* | 47.3±30.9* | 31.1±11.6* | 0.54 |
| MPO 3 | 38.9±25.6* | 36.6±26.9 | 32.5±23.7* | 46.1±33.4 | 0.66 |
| MPO 4 | 27.9±17.7 | 36.8±20.6 | 24.7±15.6* | 37.9±55.2 | 0.7 |
| P [in group] | * | * | * | * | - |
| APELIN [1.01-2.38 ng/ml] | |||||
| APELIN 1 | 1.1±0.47* | 1±0.42* | 1.6±0.47* | 0.7±0.14* | 0.002 |
| APELIN 2 | 0.6±0.20* | 0.50±0.18* | 0.65±0.18* | 0.46±0.12* | 0.16 |
| APELIN 3 | 0.93±0.82 | 0.70±0.20 | 1.0±0.38* | 0.62±0.22* | 0.02 |
| APELIN 4 | 1.0±0.77 | 0.79±0.46 | 1.4±0.95 | 1.0±0.70 | 0.21 |
| P [in group] | * | * | * | * | - |
| Von Wilebrand Factor [0.3-1.57] IU/ml | |||||
| VWF 1 | 1.53±0.37* | 2.18±1.77* | 1.81±0.64* | 1.92±0.52* | 0.57 |
| VWF 2 | 3.0±2.3 | 3.0±2.0 | 3.4±2.1* | 2.1±0.60 | 0.45 |
| VWF 3 | 3.5±1.6* | 3.3±1.6 | 3.4±1.4* | 2.8±0.65* | 0.77 |
| VWF 4 | 3.7±1.9* | 3.4±0.83* | 3.7±1.0* | 3.1±0.45* | 0.87 |
| P [in group] | * | * | * | * | - |
| HOMOCYSTEINE [0-11.4µmol/L] | |||||
| HOMOCYSTEINE 1 | 10±5.0 | 11.1±7.3 | 10.1±4.5 | 11.2±7.0 | 0.95 |
| HOMOCYSTEINE 2 | 10.6±7.7 | 10.1±5.3 | 11.7±5.9 | 12.0±7.4 | 0.97 |
| HOMOCYSTEINE 3 | 9.1±8.8 | 7.8±5.1 | 8.5±5.2 | 4.0±2.1 | 0.49 |
| HOMOCYSTEINE 4 | 18.5±18.0 | 19.8±14.9 | 13.1±3.8 | 10.2±5.3 | 0.58 |
| P [in group] | - | - | - | - | - |
| ADMA [0.22-0.69 µmol/L] [Asymmetric dimethyl-L-arginin] | |||||
| ADMA 1 | 0.64±0.15 | 0.58±0.9* | 0.59±0.17 | 0.68±0.14* | 0.67 |
| ADMA 2 | 0.63±0.13 | 0.63±0.11 | 0.57±0.12 | 0.63±0.13 | 0.58 |
| ADMA 3 | 0.53±0.19 | 0.44±0.16* | 0.49±0.16 | 0.45±0.15* | 0.66 |
| ADMA 4 | 0.73±0.12 | 0.64±0.27 | 0.56±0.11 | 0.64±0.10 | 0.35 |
| P [in group] | - | * | - | * | - |
Inflammatory cytokine levels according to groups [p<0>
There is an anxiety related with quickly growing diabetes epidemic which is a significant health problem. It was calculated as 16.5 % [6.5 million adults] in TURDEP II population based survey as a prevalence which was including 26,499 adults in Turkey. The increment rate was 90 % when compared with the TURDEP I study during the last 12 years [21]. Approximately, 30-40 % of patients undergoing coronary artery bypass surgery [CABG] have diabetes mellitus with many have undiagnosed diabetes or impaired glucose tolerance [22, 23]. Furthermore, diabetic coronary artery bypass patients are more probable to have a repeat revascularization procedure. They have a 24% increased risk of secondary procedure for cardiac-related issues, and a 44% higher risk for rehospitalization [24, 25]. Diabetic patients have more diffuse coronary artery disease, impaired fibrinolytic and platelet function and abnormal endothelial function. All these decrease the graft patency’s and eventually increase the perioperative mortality [26, 27]. Although these outcomes were thought to be irreversible, it was shown that by achieving glycemic control in patients with diabetes mellitus undergoing CABG surgery, perioperative morbidity and mortality can be reduced, long-term survival improved, and the incidence of recurrent ischemic events decreased [25-27].
Diabetes is a marker for high-risk mortality-morbidity effect and expensive health care after CABG [1]. It is obvious that the increasing proportion of patients needing CABG who have diabetes, are a growing challenge. The oscillations in levels of glycemic control have continued for a research subject in the heterogeneous ICU population. Therefore, regarding the risks and benefits of tight glycemic homeostasis in this specific patient group, it is important to schedule the operating time following the glycemic control. It is so necessary to understand the pathology that exists in this diabetic patient population. Uncontrolled glucose levels particularly in patients who will experience CABG surgery and extracorporeal circulation has more dramatic consequences than any other operative scenario. The response to cardiac surgery and cardiopulmonary bypass with release of cytokines is significant. All of these factors play an important role in glucose metabolism and consequences. Hyperglycemia has numerous deleterious effects as, decreased vasodilation through impaired endothelial nitric oxide generation, increased expression of endothelial adhesion molecules and increased cytokine levels. These changes may reach undesirable response that causes to increased inflammation and organ dysfunction [1-5, 28-32].
Vascular endothelium is not a barrier, it is an organ that plays a main role in vasoregulation, platelet aggregation, leukocyte adhesion, vessel growth and fibrinolysis [27-28]. Endothelium regulates the blood flow according to myocardial need by releasing both vasodilator [NO, prostacyclin] and vasoconstrictive [Endothelin – 1, thromboxane] molecules. Endothelium also protects the internal vascular surface from cellular adhesion. Endothelium derived NO and prostacyclin inhibits platelet aggregation. Endothelial cells are non- adhesive to circulating leucocytes in normal conditions. Endothelium also regulates leukocyte differentiation and smooth muscle differentiation [31]. NO and TGFβ1 inhibits the cell growth while, PAF and Endothelin-1 promotes the cell growth.
Rh-Pat system shows endothelial dysfunction in all patients in diabetic groups [groups 2-4] who underwent coronary bypass surgery. The scores get increased following the surgery and the difference was lost. This could be the result of the aggressive insulin and antidiabetic treatment used preoperatively. Although we recognized the positive response of endothelial function for the high glucose treatment, it is difficult to realize the duration of the treatment to reach normal endothelial function. The positive inotropic support ratio is higher in diabetic groups, especially it was reached the highest ratio with 50% in group 4. This is another index of detrimental effect of diabetic injury for the coronary artery disease.
Atherosclerosis is the first step of the endothelial dysfunction. Low density lipoproteins and incorporated immune complexes are probably the main cause of endothelial dysfunction. When these molecules are oxidized on the endothelium, it cannot degrade and express surface bound molecules and release cytokines. These molecules cause migration of inflammatory cells to subendothelial space. Endothelial dysfunction occurs by two different mechanisms. First one is the acute mechanism, endothelial cells retracts, Wiedel Palade body’s expose P-Selectin and releases Von Willebrand Factor. Second mechanism is characterized by de novo protein synthesis and gene expression of E-selectin, IL8 and ICAM-1 [30-32].
The endothelial function is affected in different therapeutically approaches. Enhanced deposition of VWF, the overexpression of NO synthase and endotelin-1 is demonstrated in animal models after coronary balloon dilatation [32]. In coronary bypass surgery, arterial grafts has better long term results because these conduits has better endothelial layers. They adapts to blood flow changes and preserves antithrombotic states better than venous conduits. Arterial grafts maintains NO and prostacyclin mechanisms [33-34]. In presence of atherosclerosis, platelets express more selectins [P- Selectin], integrins [VCAM] even the endothelium is intact but dysfunctional. The activated platelets releases IL-1 and ICAM-1 to secrete monocyte chemotactic protein-1 [MCAM-1] [35]. In response to inflammatory mediators [IL-1, TNF-α, MCAM-1] that are released from activated monocytes, smooth muscle cells secrete growth factors that enhance atherogenesis. TNF- alpha is early response cytokines mainly produced by activated macrophages [monocytes]. It induces the production of several other inflammatory mediators such as IL-1, IL-6, and colony stimulating factors, prostaglandins, platelet-activating factor [PAF].
Nitric oxide levels did not show any difference among the groups but it decreased significantly in group 1, control group with time. It slightly but none significantly increased in group 3 and 4 that could be explained by the result of insulin treatment. The diabetic groups especially 3 and 4 needed to have important insulin infusions to reach the treatment targets of Portland protocol. İnsulin amount is positively correlated with the levels of apelin and so with the nitric oxide. Apelin also increased especially in group 4 with time. Although it has the lowest value among the groups, it reached a normal level with treatment. Apelin is a member of the adipokine family. It has effects on blood pressure via activation of the endothelial nitric oxide synthase and controlled by insulin resistance, obesity and hyperinsulinemia. In an observational study, serum apelin and vaspin levels were found significantly higher in patients with metabolic syndrome and coronary artery atherosclerosis. It could be used as a specific marker for insulin resistance [25].
Soluble vascular adhesion molecule levels did not differ among the groups but significantly increased in all groups during the follow up. Soluble intercellular adhesion molecule levels reached a significant level at the 4th measurement point [at first postoperative day], with the lowest value at group 4. The measured levels increased gradually in all groups during time. E-selectin, P-selectin, interleukin-6, endothelin, interleukin 1β, TNFα, myeloperoxidase, Von Willebrand factor, homocysteine and ADMA levels did not differ among the groups but changed significantly during the follow up.
Asymmetric dimethyl arginine [ADMA] is an endogenous inhibitor of nitric oxide [NO] synthases. ADMA causes endothelial dysfunction, vasoconstriction, elevation of blood pressure, and aggravation of atherosclerosis. Several studies in humans have revealed that ADMA plasma concentration is elevated in vascular diseases and increases the cardiovascular risk. Homocysteine is another marker of risk of cardiovascular disease. Studies found that for every 5-μmol/L increase in serum homocysteine concentration, the risk of ischemic heart disease increased 20% to 30%. The levels of ADMA decreased first and increased again during the measurement time points but there is not any significant difference in between the groups could be recognized.
In our study there is a significant difference between diabetic and non-diabetic patients in terms of both endothelial function and some of the inflammatory cytokines. The limitation of our study is the small number of patients in groups. It is not quite possible to find a patient with uncontrolled blood glucose level. Majority of the patients had diagnosed diabetic before the surgery and treated. Another limitation was insulin level and insulin resistance of the patients. It could be more valuable to match the results according to insulin resistance and c-peptide level. The glycemic control and insulin treatment may normalized the both endothelial function and homeostasis of mediators.
Many studies demonstrated an association between perioperative hyperglycemia and morbidity in the cardiac surgery patients. The timing of the surgery and the diabetic control are extremely important to reduce the morbidity so, the endothelial function and cytokine levels are important.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
